The global tissue diagnostics market size reached USD 5.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 9.8 Billion by 2033, exhibiting a growth rate (CAGR) of 5.64% during 2025-2033.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024
|
USD 5.8 Billion |
Market Forecast in 2033
|
USD 9.8 Billion |
Market Growth Rate 2025-2033 | 5.64% |
Tissue diagnostics include the analysis and testing of specific tissue samples by capturing the biological context of diseases. They are used to detect certain medical conditions like cancer and inflammatory disorders and reveal the exact type and degree of malignancy which assists in identifying potential causes and treatment options. Tissue diagnostics are highly accurate, inexpensive and can be carried out by different techniques like core and open biopsy. Nowadays, advanced technologies like immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology and special staining are also being employed for performing these diagnoses.
Owing to the declining fertility rates and increased life expectancy, the overall share of the geriatric population is currently experiencing steady growth worldwide. This is a crucial factor contributing to the market growth as older adults are more susceptible to chronic diseases and thus require frequent check-ups and diagnoses. Apart from this, altering food patterns, rising alcohol consumption and reduced physical activities among individuals have led to a rise in the incidences of several lifestyle diseases. In addition to this, the rising prevalence of various types of cancers among all age groups has also led to a surge in demand for these diagnostic services.
IMARC Group provides an analysis of the key trends in each sub-segment of the global tissue diagnostics market report, along with forecasts at the global and regional level from 2025-2033. Our report has categorized the market based on product type, technology, disease and end-user.
Breakup by Product Type:
Breakup by Technology:
Breakup by Disease:
Breakup by End-User:
Breakup by Region:
The report has also analysed the competitive landscape of the market with some of the key players being Roche, Danaher, Thermo Fisher Scientific, Abbott, Agilent Technologies, Merck, Sakura Finetek Japan, Abcam, BD, Qiagen, Bio SB, Biogenex, Cell Signaling Technology, etc
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Product Type, Technology, Disease, End-User, Region |
Region Covered | North America, Europe, Asia Pacific, Middle East and Africa, Latin America |
Companies Covered | Roche, Danaher, Thermo Fisher Scientific, Abbott, Agilent Technologies, Merck, Sakura Finetek Japan, Abcam, BD, Qiagen, Bio SB, Biogenex and Cell Signaling Technology |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
The global tissue diagnostics market was valued at USD 5.8 Billion in 2024.
We expect the global tissue diagnostics market to exhibit a CAGR of 5.64% during 2025-2033.
The rising adoption of tissue diagnostics in detecting the existence of cancer and analyzing other features that may assist in making disease management decisions is primarily driving the global tissue diagnostics market.
The sudden outbreak of the COVID-19 pandemic had led to the postponement of elective cancer treatment procedures to reduce the risk of the coronavirus infection upon hospital visits and interaction with healthcare professionals, thereby negatively impacting the global market for tissue diagnostics.
Based on the product type, the global tissue diagnostics market has been segmented into instruments and consumables, where consumables currently hold the majority of the total market share.
Based on the technology, the global tissue diagnostics market can be divided into immunohistochemistry, in situ hybridization, digital pathology and workflow management, and special staining. Currently, immunohistochemistry exhibits a clear dominance in the market.
Based on the disease, the global tissue diagnostics market has been categorized into breast cancer, gastric cancer, lymphoma, prostate cancer, non-small cell lung cancer, and others. Among these, breast cancer currently accounts for the largest market share.
Based on the end-user, the global tissue diagnostics market can be segregated into hospitals, research laboratories, pharmaceutical companies, contract research organizations, and others. Currently, hospitals exhibit a clear dominance in the market.
On a regional level, the market has been classified into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America, where North America currently dominates the global market.
Some of the major players in the global tissue diagnostics market include Roche, Danaher, Thermo Fisher Scientific, Abbott, Agilent Technologies, Merck, Sakura Finetek Japan, Abcam, BD, Qiagen, Bio SB, Biogenex, Cell Signaling Technology, etc.